FDA Approves Opdivo for Advanced Melanoma
- FLASCO
- March 10, 2015
- Drugs
FDA Approves Opdivo for Advanced Melanoma
The U.S. Food and Drug Administration today granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who no longer respond to other drugs. Read press releaseĀ
Click to read Opdivo Announcement
For more information Opdivo